메뉴 건너뛰기




Volumn 297, Issue 2, 2001, Pages 606-611

RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; RXP 407; UNCLASSIFIED DRUG;

EID: 0035042245     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (101)

References (24)
  • 17
    • 0030981239 scopus 로고    scopus 로고
    • Substrate dependence of angiotensin I-converting enzyme inhibition: Captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I
    • (1997) Mol Pharmacol , vol.51 , pp. 1070-1076
    • Michaud, A.1    Williams, T.A.2    Chauvet, M.T.3    Corvol, P.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.